Glucuronidation of flavonoids by recombinant UGT1A3 and UGT1A9

Biochemical Pharmacology

Volumn 76, Issue 3, 2008, Pages 416-425

  Chen, Yakun ^a   Xie, Shenggu ^a   Chen, Shuqing ^a   Zeng, Su ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Flavonoids; Glucuronidation; Monoglucuronide; UGT1A3; UGT1A9

Indexed keywords

AGLYCONE; APIGENIN; AURANTIIN; AVICULARINE; BAICALIN; DAIDZEIN; FARREROL; FLAVONOID; FLAVONOID GLYCOSIDE; GLUCURONOSYLTRANSFERASE 1A3; GLUCURONOSYLTRANSFERASE 1A9; HESPERIDIN; HIRSUTINE; HYPERIN; ISOFORMONONETIN; ISORHAMNETIN; KAEMPFEROL; LUTEOLIN; MORIN; PUERARIN; QUERCETIN; QUERCETIN XYLOPYRANOSIDE; RUTOSIDE; SILIBININ;

ARTICLE; CATALYSIS; DRUG CONJUGATION; DRUG STRUCTURE; ENZYME KINETICS; GLUCURONIDATION; KINETICS; LIQUID CHROMATOGRAPHY; OXIDATIVE STRESS; PRIORITY JOURNAL;

ANIMALS; BACULOVIRIDAE; CATALYSIS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FLAVONOIDS; GLUCURONIDASE; GLUCURONIDES; GLUCURONOSYLTRANSFERASE; HUMANS; HYDROLYSIS; INSECTS; KINETICS; MOLECULAR STRUCTURE; RECOMBINANT PROTEINS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TRANSFECTION;

EID: 46649101589     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2008.05.007     Document Type: Article

References (31)

1. Crespy V., Morand C., Besson C., Cotelle N., Vezin H., Demigne C., et al. The splanchnic metabolism of flavonoids highly differed according to the nature of the compound. Am J Physiol Gastrointest Liver Physiol 284 (2003) G980-G988
2. Rice-Evans C. Flavonoid antioxidants. Curr Med Chem 8 (2001) 797-807
3. Scalbert A., and Williamson G. Dietary intake and bioavailability of polyphenols. J Nutr 130 (2000) 2073S-2085S
4. Manach C., Scalbert A., Morand C., Rémésy C., and Jiménez L. Polyphenols: food sources and bioavailability. Am J Clin Nutr 79 (2004) 727-747
5. Chen Y.K., Chen S.Q., Li X., and Zeng S. Quantitative regioselectivity of glucuronidation of quercetin by recombinant UDP-glucuronosyltransferases 1A9 and 1A3 using enzymatic kinetic parameters. Xenobiotica 35 (2005) 943-954
6. Boersma M.G., Woude H.V.D., Bogaards J., Boeren S., Vervoort J., Cnubben N.H., et al. Regioselectivity of phase II metabolism of luteolin and quercetin by UDP-glucuronosyl transferases. Chem Res Toxicol 15 (2002) 662-670
7. Mojarrabi B., Butler R., and Mackenzie P.I. cDNA cloning and characterization of the human UDP glucuronosyltransferase, UGT1A3. Biochem Biophys Res Commun 225 (1996) 785-790
8. Chen Y., Chen S., Li X., Wang X., and Zeng S. Genetic variants of human UGT1A3: functional characterization and frequency distribution in a Chinese Han population. Drug Metab Dispos 34 (2006) 1462-1467
9. Green M.D., King C.D., Mojarrabi B., Mackenzie P.I., and Tephly T.R. Glucuronidation of amines and other xenobiotics catalyzed by expressed human UDP-glucuronosyltransferase 1A3. Drug Metab Dispos 26 (1998) 507-512
10. Houston J.B., Kenworthy K.E., and Galetin A. Typical and atypical enzyme kinetics. In: Fisher M., Lee J., and Obach S. (Eds). Drug metabolizing enzymes: cytochrome P450 and other enzymes in drug discovery and development (2003), Fontis Media, Lausanne 211-254
11. Hou Y.C., Chao P.D., Ho H.J., Wen C.C., and Hsiu S.L. Profound difference in pharmacokinetics between morin and its isomer quercetin in rats. J Pharm Pharmacol 55 (2003) 199-203
12. DuPont M.S., Day A.J., Bennett R.N., Mellon F.A., and Kroon P.A. Absorption of kaempferol from endive, a source of kaempferol-3-glucuronide, in humans. Eur J Clin Nutr 58 (2004) 947-954
13. Rickling B., Hans B., Kramarczyk R., Krumbiegel G., and Weyhenmeyer R. Two highperformance liquid chromatographic assays for the determination of free and total silibinin diastereomers in plasma using column switching with electrochemical detection and reversedphase chromatography with ultraviolet detection. J Chromatogr B, Biomed Appl 670 (1995) 267-277
14. Han Y.H., Lou H.X., Ren D.M., Sun L.R., Ma B., and Ji M. Stereoselective metabolism of silybin diastereoisomers in the glucuronidation process. J Pharm Biomed Anal 34 (2004) 1071-1078
15. Brown D.M., Kelly G.E., and Husband A.J. Flavonoid compounds in maintenance of prostate health and prevention and treatment of cancer. Mol Biotechnol 30 (2005) 253-270
16. Manach C., Mazur A., and Scalbert A. Polyphenols and prevention of cardiovascular diseases. Curr Opin Lipidol 16 (2005) 77-84
17. Rivera F., Urbanavicius J., Gervaz E., Morquio A., and Dajas F. Some aspects of the in vivo neuroprotective capacity of flavonoids: bioavailability and structure-activity relationship. Neurotox Res 6 (2004) 543-553
18. Manach C., Williamson G., Morand C., Scalbert A., and Rémésy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 81 (2005) 230S-242S
19. Hsiu S.L., Tsao C.W., Tsai Y.C., Ho H.J., and Chao P.D. Determinations of morin, quercetin and their conjugate metabolites in serum. Biol Pharm Bull 24 (2001) 967-969
20. Janisch K.M., Williamson G., Needs P., and Plumb G.W. Properties of quercetin conjugates: modulation of LDL oxidation and binding to human serum albumin. Free Radic Res 38 (2004) 877-884
21. Plumb G.W., Price K.R., and Williamson G. Antioxidant properties of flavonol glycosides from green beans. Redox Rep 4 (1999) 123-127
22. Fang S.H., Hou Y.C., Chang W.C., Hsiu S.L., Chao P.D., and Chiang B.L. Morin sulfates/glucuronides exert anti-inflammatory activity on activated macrophages and decreased the incidence of septic shock. Life Sci 74 (2003) 743-756
23. de Santi C., Pietrabissa A., Mosca F., and Pacifici G.M. Glucuronidation of resveratrol, a natural product present in grape and wine, in the human liver. Xenobiotica 30 (2000) 1047-1054
24. Otake Y., Hsieh F., and Walle T. Glucuronidation versus oxidation of the flavonoid galangin by human liver microsomes and hepatocytes. Drug Metab Dispos 30 (2002) 576-581
25. Li X.M., Li X., Chen S.Q., and Zeng S. Construction of pcDNA3 1-UDPGT1A9 expression plasmid and establishment of its transgenic cell line. Chin J Pharmacol Toxicol 8 (2004) 115-120
26. Yoshizumi M., Tsuchiya K., Suzaki Y., Kirima K., Kyaw M., Moon J.H., et al. Quercetin glucuronide prevents VSMC hypertrophy by angiotensin II via the inhibition of JNK and AP-1 signaling pathway. Biochem Biophys Res Commun 293 (2002) 1458-1465
27. Graefe E.U., Wittig J., Mueller S., Riethling A.K., Uehleke B., Drewelow B., et al. Pharmacokinetics and bioavailability of quercetin glycosides in humans. J Clin Pharmacol 41 (2001) 492-499
28. Talavéra S., Felgines C., Texier O., Besson C., Lamaison J.-L., and Rémésy C. Anthocyanins are efficiently absorbed from the stomach in anesthetized rats. J Nutr 133 (2003) 4178£-4182£
29. Wu X., Cao G., and Prior R.L. Absorption and metabolism of anthocyanins in elderly women after consumption of elderberry or blueberry. J Nutr 132 (2002) 1865-1871
30. Oliveira E.J., and Watson D.G. In vitro glucuronidation of kaempferol and quercetin by human UGT-1A9 microsomes. FEBS Lett 471 (2000) 1-6
31. Xie S., Chen Y., Chen S., and Zeng S. Glucuronidation of flavonoids by human UGT1A3, UGT1A9 and structure-activity relationships. Drug Metab Rev 38 Suppl. 3 (2006) 129